ESMO: Metastatic Breast Cancer
<乌鸦传媒 class="page-description">European Society for Medical OncologyMore in ESMO: Metastatic Breast Cancer
A three-part quiz covering our series on advanced breast cancer
Nov 26, 2023
It may only get more complicated as new options are approved
Nov 26, 2023
Data have narrowed first- and second-line choices, but decisions must be tailored to the patient
Nov 21, 2023
Antibody-drug conjugates in particular may present clinicians with less familiar side effects
Nov 15, 2023
A three-question quiz on HER2-low disease, brain metastases, and progression on CDK4/6 inhibitors
Sep 30, 2022
Rapidly changing landscape has brought new targeted agents and made staying up-to-date vital
Sep 30, 2022
The new category could encompass a majority of metastatic, unresectable breast cancers
Sep 09, 2022
Some patients live years with advanced disease; when should end-of-life care talks happen?
Sep 30, 2021
